Patent · US Expired

Methods and compositions utilizing quinazolinones

US7294634B2 · kind B2 · utility

26Cited by
93References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2004
Grant dateNov 13, 2007
Priority date
Expiry dateMay 8, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/91
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.